What is your clinical pathway when a transplant candidate reports abstinence but has a positive phosphatidylethanol (PeTH), including how you confirm results and decide on addiction-medicine involvement and listing implications?

We address the discrepancy directly with the patient. If the liver disease is moderate, we decline the patient as a candidate and require enrollment in an AUD treatment plan along with monthly Peth testing in order to eventually list. Medicines to prevent cravings are offered at hospital discharge. ...